Request for Covid-19 Impact Assessment of this Report
This research report categorizes the global Drug-Eluting Balloon market by top players/brands, region, type and end user. This report also studies the global Drug-Eluting Balloon market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The global Drug-Eluting Balloon market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025. The objectives of this study are to define, segment, and project the size of the Drug-Eluting Balloon market based on company, product type, end user and key regions.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Boston Scientific
Medtronic
Cook Medical
C.R. Bard
B. Braun
Eurocor GmbH
Blue Medical
Bayer
Aachen Resonance
Acrostak
Market size by Product
Type I
Type II
Market size by End User
Treatment of In-stent Restenosis (ISR)
Treatment of Small Vessel Disease (SVD)
Treatment of Bifurcation Stenoses
Treatment of Primary Coronary Artery Disease
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Drug-Eluting Balloon market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.
To understand the structure of Drug-Eluting Balloon market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Drug-Eluting Balloon companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Drug-Eluting Balloon submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Drug-Eluting Balloon are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Drug-Eluting Balloon market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Study Coverage
1.1 Drug-Eluting Balloon Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Drug-Eluting Balloon Market Size Growth Rate by Product
1.4.2 Type I
1.4.3 Type II
1.5 Market by End User
1.5.1 Global Drug-Eluting Balloon Market Size Growth Rate by End User
1.5.2 Treatment of In-stent Restenosis (ISR)
1.5.3 Treatment of Small Vessel Disease (SVD)
1.5.4 Treatment of Bifurcation Stenoses
1.5.5 Treatment of Primary Coronary Artery Disease
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Drug-Eluting Balloon Market Size
2.1.1 Global Drug-Eluting Balloon Revenue 2013-2025
2.1.2 Global Drug-Eluting Balloon Sales 2013-2025
2.2 Drug-Eluting Balloon Growth Rate by Regions
2.2.1 Global Drug-Eluting Balloon Sales by Regions
2.2.2 Global Drug-Eluting Balloon Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Drug-Eluting Balloon Sales by Manufacturers
3.1.1 Drug-Eluting Balloon Sales by Manufacturers
3.1.2 Drug-Eluting Balloon Sales Market Share by Manufacturers
3.1.3 Global Drug-Eluting Balloon Market Concentration Ratio (CR5 and HHI)
3.2 Drug-Eluting Balloon Revenue by Manufacturers
3.2.1 Drug-Eluting Balloon Revenue by Manufacturers (2013-2018)
3.2.2 Drug-Eluting Balloon Revenue Share by Manufacturers (2013-2018)
3.3 Drug-Eluting Balloon Price by Manufacturers
3.4 Drug-Eluting Balloon Manufacturing Base Distribution, Product Types
3.4.1 Drug-Eluting Balloon Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Drug-Eluting Balloon Product Type
3.4.3 Date of International Manufacturers Enter into Drug-Eluting Balloon Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Drug-Eluting Balloon Sales by Product
4.2 Global Drug-Eluting Balloon Revenue by Product
4.3 Drug-Eluting Balloon Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Drug-Eluting Balloon Breakdown Data by End User
6 North America
6.1 North America Drug-Eluting Balloon by Countries
6.1.1 North America Drug-Eluting Balloon Sales by Countries
6.1.2 North America Drug-Eluting Balloon Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Drug-Eluting Balloon by Product
6.3 North America Drug-Eluting Balloon by End User
7 Europe
7.1 Europe Drug-Eluting Balloon by Countries
7.1.1 Europe Drug-Eluting Balloon Sales by Countries
7.1.2 Europe Drug-Eluting Balloon Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Drug-Eluting Balloon by Product
7.3 Europe Drug-Eluting Balloon by End User
8 Asia Pacific
8.1 Asia Pacific Drug-Eluting Balloon by Countries
8.1.1 Asia Pacific Drug-Eluting Balloon Sales by Countries
8.1.2 Asia Pacific Drug-Eluting Balloon Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Drug-Eluting Balloon by Product
8.3 Asia Pacific Drug-Eluting Balloon by End User
9 Central & South America
9.1 Central & South America Drug-Eluting Balloon by Countries
9.1.1 Central & South America Drug-Eluting Balloon Sales by Countries
9.1.2 Central & South America Drug-Eluting Balloon Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Drug-Eluting Balloon by Product
9.3 Central & South America Drug-Eluting Balloon by End User
10 Middle East and Africa
10.1 Middle East and Africa Drug-Eluting Balloon by Countries
10.1.1 Middle East and Africa Drug-Eluting Balloon Sales by Countries
10.1.2 Middle East and Africa Drug-Eluting Balloon Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Drug-Eluting Balloon by Product
10.3 Middle East and Africa Drug-Eluting Balloon by End User
11 Company Profiles
11.1 Boston Scientific
11.1.1 Boston Scientific Company Details
11.1.2 Company Business Overview
11.1.3 Boston Scientific Drug-Eluting Balloon Sales, Revenue and Gross Margin (2013-2018)
11.1.4 Boston Scientific Drug-Eluting Balloon Products Offered
11.1.5 Boston Scientific Recent Development
11.2 Medtronic
11.2.1 Medtronic Company Details
11.2.2 Company Business Overview
11.2.3 Medtronic Drug-Eluting Balloon Sales, Revenue and Gross Margin (2013-2018)
11.2.4 Medtronic Drug-Eluting Balloon Products Offered
11.2.5 Medtronic Recent Development
11.3 Cook Medical
11.3.1 Cook Medical Company Details
11.3.2 Company Business Overview
11.3.Cook Medical Drug-Eluting Balloon Sales, Revenue and Gross Margin (2013-2018)
11.3.4 Cook Medical Drug-Eluting Balloon Products Offered
11.3.5 Cook Medical Recent Development
11.4 C.R. Bard
11.4.1 C.R. Bard Company Details
11.4.2 Company Business Overview
11.4.3 C.R. Bard Drug-Eluting Balloon Sales, Revenue and Gross Margin (2013-2018)
11.4.4 C.R. Bard Drug-Eluting Balloon Products Offered
11.4.5 C.R. Bard Recent Development
11.5 B. Braun
11.5.1 B. Braun Company Details
11.5.2 Company Business Overview
11.5.3 B. Braun Drug-Eluting Balloon Sales, Revenue and Gross Margin (2013-2018)
11.5.4 B. Braun Drug-Eluting Balloon Products Offered
11.5.5 B. Braun Recent Development
11.6 Eurocor GmbH
11.6.1 Eurocor GmbH Company Details
11.6.2 Company Business Overview
11.6.3 Eurocor GmbH Drug-Eluting Balloon Sales, Revenue and Gross Margin (2013-2018)
11.6.4 Eurocor GmbH Drug-Eluting Balloon Products Offered
11.6.5 Eurocor GmbH Recent Development
11.7 Blue Medical
11.7.1 Blue Medical Company Details
11.7.2 Company Business Overview
11.7.3 Blue Medical Drug-Eluting Balloon Sales, Revenue and Gross Margin (2013-2018)
11.7.4 Blue Medical Drug-Eluting Balloon Products Offered
11.7.5 Blue Medical Recent Development
11.8 Bayer
11.8.1 Bayer Company Details
11.8.2 Company Business Overview
11.8.3 Bayer Drug-Eluting Balloon Sales, Revenue and Gross Margin (2013-2018)
11.8.4 Bayer Drug-Eluting Balloon Products Offered
11.8.5 Bayer Recent Development
11.9 Aachen Resonance
11.9.1 Aachen Resonance Company Details
11.9.2 Company Business Overview
11.9.3 Aachen Resonance Drug-Eluting Balloon Sales, Revenue and Gross Margin (2013-2018)
11.9.4 Aachen Resonance Drug-Eluting Balloon Products Offered
11.9.5 Aachen Resonance Recent Development
11.10 Acrostak
11.10.1 Acrostak Company Details
11.10.2 Company Business Overview
11.10.3 Acrostak Drug-Eluting Balloon Sales, Revenue and Gross Margin (2013-2018)
11.10.4 Acrostak Drug-Eluting Balloon Products Offered
11.10.5 Acrostak Recent Development
12 Future Forecast
12.1 Drug-Eluting Balloon Market Forecast by Regions
12.1.1 Global Drug-Eluting Balloon Sales Forecast by Regions 2018-2025
12.1.2 Global Drug-Eluting Balloon Revenue Forecast by Regions 2018-2025
12.2 Drug-Eluting Balloon Market Forecast by Product
12.2.1 Global Drug-Eluting Balloon Sales Forecast by Product 2018-2025
12.2.2 Global Drug-Eluting Balloon Revenue Forecast by Product 2018-2025
12.3 Drug-Eluting Balloon Market Forecast by End User
12.4 North America Drug-Eluting Balloon Forecast
12.5 Europe Drug-Eluting Balloon Forecast
12.6 Asia Pacific Drug-Eluting Balloon Forecast
12.7 Central & South America Drug-Eluting Balloon Forecast
12.8 Middle East and Africa Drug-Eluting Balloon Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Drug-Eluting Balloon Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Drug-Eluting Balloon Product Picture
Table Drug-Eluting Balloon Market Segments
Table Key Manufacturers Drug-Eluting Balloon Covered
Table Global Drug-Eluting Balloon Market Size Growth Rate by Product 2018-2025 (K Units) & (Million US$)
Figure Global Drug-Eluting Balloon Sales Market Share by Product 2013-2025
Figure Type I Product Picture
Table Major Manufacturers of Type I
Figure Type II Product Picture
Table Major Manufacturers of Type II
Table Global Drug-Eluting Balloon Market Size Growth Rate by End User 2018-2025 (K Units)
Figure Treatment of In-stent Restenosis (ISR)
Figure Treatment of Small Vessel Disease (SVD)
Figure Treatment of Bifurcation Stenoses
Figure Treatment of Primary Coronary Artery Disease
Figure Drug-Eluting Balloon Report Years Considered
Figure Global Drug-Eluting Balloon Market Size 2013-2025 (Million US$)
Figure Global Drug-Eluting Balloon Sales 2013-2025 (K Units)
Table Global Drug-Eluting Balloon Market Size by Regions 2013-2018 (K Units) & (Million US$)
Table Global Drug-Eluting Balloon Sales by Regions 2013-2018 (K Units)
Table Global Drug-Eluting Balloon Sales Market Share by Regions 2013-2018
Figure Global Drug-Eluting Balloon Sales Market Share by Regions 2013-2018
Figure 2017 Global Drug-Eluting Balloon Sales Market Share by Regions
Table Global Drug-Eluting Balloon Revenue by Regions 2013-2018 (Million US$)
Table Global Drug-Eluting Balloon Revenue Market Share by Regions 2013-2018
Figure Global Drug-Eluting Balloon Revenue Market Share by Regions 2013-2018
Figure 2017 Global Drug-Eluting Balloon Revenue Market Share by Regions
Table Global Drug-Eluting Balloon Sales by Manufacturers (2013-2018) (K Units)
Table Global Drug-Eluting Balloon Sales Share by Manufacturers (2013-2018)
Figure Global Drug-Eluting Balloon Sales Share by Manufacturers in 2017
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Drug-Eluting Balloon Revenue by Manufacturers (2013-2018) (Million USD)
Table Drug-Eluting Balloon Revenue Share by Manufacturers (2013-2018)
Figure Drug-Eluting Balloon Value Share by Manufacturers in 2017
Table Key Manufacturers Drug-Eluting Balloon Price (2013-2018) (USD/Unit)
Table Drug-Eluting Balloon Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Drug-Eluting Balloon Product Type
Table Date of International Manufacturers Enter into Drug-Eluting Balloon Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Drug-Eluting Balloon Sales by Product (2013-2018) (K Units)
Table Global Drug-Eluting Balloon Sales Share by Product (2013-2018)
Figure Global Drug-Eluting Balloon Sales Market Share by Product (2013-2018)
Figure Global Drug-Eluting Balloon Sales Market Share by Product in 2017
Table Global Drug-Eluting Balloon Revenue by Product (2013-2018) (Million US$)
Table Global Drug-Eluting Balloon Revenue Share by Product (2013-2018)
Figure Global Drug-Eluting Balloon Revenue Market Share by Product (2013-2018)
Figure Global Drug-Eluting Balloon Revenue Market Share by Product in 2017
Table Drug-Eluting Balloon Price by Product 2013-2018 (USD/Unit)
Table Global Drug-Eluting Balloon Sales by End User (2013-2018) (K Units)
Table Global Drug-Eluting Balloon Sales Share by End User (2013-2018)
Figure Global Sales Drug-Eluting Balloon Market Share by End User (2013-2018)
Figure Global Sales Drug-Eluting Balloon Market Share by End User in 2017
Figure North America Drug-Eluting Balloon Sales Growth Rate 2013-2018 (K Units)
Figure North America Drug-Eluting Balloon Revenue Growth Rate 2013-2018 (Million US$)
Table North America Drug-Eluting Balloon Sales by Countries (2013-2018) (K Units)
Table North America Drug-Eluting Balloon Sales Market Share by Countries (2013-2018)
Figure 2017 North America Drug-Eluting Balloon Sales Market Share by Countries
Table North America Drug-Eluting Balloon Revenue by Countries (2013-2018) (Million US$)
Table North America Drug-Eluting Balloon Revenue Market Share by Countries (2013-2018)
Figure 2017 North America Drug-Eluting Balloon Revenue Market Share by Countries
Figure United States Drug-Eluting Balloon Sales Growth Rate (2013-2018) (K Units)
Figure United States Drug-Eluting Balloon Revenue Growth Rate (2013-2018) (K Units)
Figure Canada Drug-Eluting Balloon Sales Growth Rate (2013-2018) (K Units)
Figure Canada Drug-Eluting Balloon Revenue Growth Rate (2013-2018) (Million US$)
Figure Mexico Drug-Eluting Balloon Sales Growth Rate (2013-2018) (K Units)
Figure Mexico Drug-Eluting Balloon Revenue Growth Rate (2013-2018) (Million US$)
Table North America Drug-Eluting Balloon Sales by Product (2013-2018) (K Units)
Table North America Drug-Eluting Balloon Sales Market Share by Product (2013-2018)
Figure 2017 North America Drug-Eluting Balloon Market Share by Product
Table North America Drug-Eluting Balloon Sales by End User (2013-2018) (K Units)
Table North America Drug-Eluting Balloon Sales Market Share by End User (2013-2018)
Figure 2017 North America Drug-Eluting Balloon Market Share by End User
Figure Europe Drug-Eluting Balloon Sales Growth Rate 2013-2018 (K Units)
Figure Europe Drug-Eluting Balloon Revenue Growth Rate 2013-2018 (Million US$)
Table Europe Drug-Eluting Balloon Sales by Countries (2013-2018) (K Units)
Table Europe Drug-Eluting Balloon Sales Market Share by Countries (2013-2018)
Figure 2017 Europe Drug-Eluting Balloon Sales Market Share by Countries
Table Europe Drug-Eluting Balloon Revenue by Countries (2013-2018) (Million US$)
Table Europe Drug-Eluting Balloon Revenue Market Share by Countries (2013-2018)
Figure 2017 Europe Drug-Eluting Balloon Revenue Market Share by Countries
Figure Germany Drug-Eluting Balloon Sales Growth Rate (2013-2018) (K Units)
Figure Germany Drug-Eluting Balloon Revenue Growth Rate (2013-2018) (Million US$)
Figure France Drug-Eluting Balloon Sales Growth Rate (2013-2018) (K Units)
Figure France Drug-Eluting Balloon Revenue Growth Rate (2013-2018) (Million US$)
Figure UK Drug-Eluting Balloon Sales Growth Rate (2013-2018) (K Units)
Figure UK Drug-Eluting Balloon Revenue Growth Rate (2013-2018) (Million US$)
Figure Italy Drug-Eluting Balloon Sales Growth Rate (2013-2018) (K Units)
Figure Italy Drug-Eluting Balloon Revenue Growth Rate (2013-2018) (Million US$)
Figure Russia Drug-Eluting Balloon Sales Growth Rate (2013-2018) (K Units)
Figure Russia Drug-Eluting Balloon Revenue Growth Rate (2013-2018) (Million US$)
Table Europe Drug-Eluting Balloon Sales by Product (2013-2018) (K Units)
Table Europe Drug-Eluting Balloon Sales Market Share by Product (2013-2018)
Figure 2017 Europe Drug-Eluting Balloon Market Share by Product
Table Europe Drug-Eluting Balloon Sales by End User (2013-2018) (K Units)
Table Europe Drug-Eluting Balloon Sales Market Share by End User (2013-2018)
Figure 2017 Europe Drug-Eluting Balloon Market Share by End User
Figure Asia Pacific Drug-Eluting Balloon Sales Growth Rate 2013-2018 (K Units)
Figure Asia Pacific Drug-Eluting Balloon Revenue Growth Rate 2013-2018 (Million US$)
Table Asia Pacific Drug-Eluting Balloon Sales by Countries (2013-2018) (K Units)
Table Asia Pacific Drug-Eluting Balloon Sales Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Drug-Eluting Balloon Sales Market Share by Countries
Table Asia Pacific Drug-Eluting Balloon Revenue by Countries (2013-2018) (Million US$)
Table Asia Pacific Drug-Eluting Balloon Revenue Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Drug-Eluting Balloon Revenue Market Share by Countries
Figure China Drug-Eluting Balloon Sales Growth Rate (2013-2018) (K Units)
Figure China Drug-Eluting Balloon Revenue Growth Rate (2013-2018) (Million US$)
Figure Japan Drug-Eluting Balloon Sales Growth Rate (2013-2018) (K Units)
Figure Japan Drug-Eluting Balloon Revenue Growth Rate (2013-2018) (Million US$)
Figure Korea Drug-Eluting Balloon Sales Growth Rate (2013-2018) (K Units)
Figure Korea Drug-Eluting Balloon Revenue Growth Rate (2013-2018) (Million US$)
Figure India Drug-Eluting Balloon Sales Growth Rate (2013-2018) (K Units)
Figure India Drug-Eluting Balloon Revenue Growth Rate (2013-2018) (Million US$)
Figure Australia Drug-Eluting Balloon Sales Growth Rate (2013-2018) (K Units)
Figure Australia Drug-Eluting Balloon Revenue Growth Rate (2013-2018) (Million US$)
Figure Indonesia Drug-Eluting Balloon Sales Growth Rate (2013-2018) (K Units)
Figure Indonesia Drug-Eluting Balloon Revenue Growth Rate (2013-2018) (Million US$)
Figure Malaysia Drug-Eluting Balloon Sales Growth Rate (2013-2018) (K Units)
Figure Malaysia Drug-Eluting Balloon Revenue Growth Rate (2013-2018) (Million US$)
Figure Philippines Drug-Eluting Balloon Sales Growth Rate (2013-2018) (K Units)
Figure Philippines Drug-Eluting Balloon Revenue Growth Rate (2013-2018) (Million US$)
Figure Thailand Drug-Eluting Balloon Sales Growth Rate (2013-2018) (K Units)
Figure Thailand Drug-Eluting Balloon Revenue Growth Rate (2013-2018) (Million US$)
Figure Vietnam Drug-Eluting Balloon Sales Growth Rate (2013-2018) (K Units)
Figure Vietnam Drug-Eluting Balloon Revenue Growth Rate (2013-2018) (Million US$)
Figure Singapore Drug-Eluting Balloon Sales Growth Rate (2013-2018) (K Units)
Figure Singapore Drug-Eluting Balloon Revenue Growth Rate (2013-2018) (Million US$)
Table Asia Pacific Drug-Eluting Balloon Sales by Product (2013-2018) (K Units)
Table Asia Pacific Drug-Eluting Balloon Sales Market Share by Product (2013-2018)
Figure 2017 Asia Pacific Drug-Eluting Balloon Market Share by Product
Table Asia Pacific Drug-Eluting Balloon Sales by End User (2013-2018) (K Units)
Table Asia Pacific Drug-Eluting Balloon Sales Market Share by End User (2013-2018)
Figure 2017 Asia Pacific Drug-Eluting Balloon Market Share by End User
Figure Central & South America Drug-Eluting Balloon Sales Growth Rate 2013-2018 (K Units)
Figure Central & South America Drug-Eluting Balloon Revenue Growth Rate 2013-2018 (Million US$)
Table Central & South America Drug-Eluting Balloon Sales by Countries (2013-2018) (K Units)
Table Central & South America Drug-Eluting Balloon Sales Market Share by Countries (2013-2018)
Figure 2017 Central & South America Drug-Eluting Balloon Sales Market Share by Countries
Table Central & South America Drug-Eluting Balloon Revenue by Countries (2013-2018) (Million US$)
Table Central & South America Drug-Eluting Balloon Revenue Market Share by Countries (2013-2018)
Figure 2017 Central & South America Drug-Eluting Balloon Revenue Market Share by Countries
Figure Brazil Drug-Eluting Balloon Sales Growth Rate (2013-2018) (K Units)
Figure Brazil Drug-Eluting Balloon Revenue Growth Rate (2013-2018) (Million US$)
Figure Argentina Drug-Eluting Balloon Sales Growth Rate (2013-2018) (K Units)
Figure Argentina Drug-Eluting Balloon Revenue Growth Rate (2013-2018) (Million US$)
Table Central & South America Drug-Eluting Balloon Sales by Product (2013-2018) (K Units)
Table Central & South America Drug-Eluting Balloon Sales Market Share by Product (2013-2018)
Figure 2017 Central & South America Drug-Eluting Balloon Market Share by Product
Table Central & South America Drug-Eluting Balloon Sales by End User (2013-2018) (K Units)
Table Central & South America Drug-Eluting Balloon Sales Market Share by End User (2013-2018)
Figure 2017 Central & South America Drug-Eluting Balloon Market Share by End User
Figure Middle East and Africa Drug-Eluting Balloon Sales Growth Rate 2013-2018 (K Units)
Figure Middle East and Africa Drug-Eluting Balloon Revenue Growth Rate 2013-2018 (Million US$)
Table Middle East and Africa Drug-Eluting Balloon Sales by Countries (2013-2018) (K Units)
Table Middle East and Africa Drug-Eluting Balloon Sales Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Drug-Eluting Balloon Sales Market Share by Countries
Table Middle East and Africa Drug-Eluting Balloon Revenue by Countries (2013-2018) (Million US$)
Table Middle East and Africa Drug-Eluting Balloon Revenue Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Drug-Eluting Balloon Revenue Market Share by Countries
Figure GCC Countries Drug-Eluting Balloon Sales Growth Rate (2013-2018) (K Units)
Figure GCC Countries Drug-Eluting Balloon Revenue Growth Rate (2013-2018) (Million US$)
Figure Turkey Drug-Eluting Balloon Sales Growth Rate (2013-2018) (K Units)
Figure Turkey Drug-Eluting Balloon Revenue Growth Rate (2013-2018) (Million US$)
Figure Egypt Drug-Eluting Balloon Sales Growth Rate (2013-2018) (K Units)
Figure Egypt Drug-Eluting Balloon Revenue Growth Rate (2013-2018) (Million US$)
Figure South Africa Drug-Eluting Balloon Sales Growth Rate (2013-2018) (K Units)
Figure South Africa Drug-Eluting Balloon Revenue Growth Rate (2013-2018) (Million US$)
Table Middle East and Africa Drug-Eluting Balloon Sales by Product (2013-2018) (K Units)
Table Middle East and Africa Drug-Eluting Balloon Sales Market Share by Product (2013-2018)
Figure 2017 Middle East and Africa Drug-Eluting Balloon Market Share by Product
Table Middle East and Africa Drug-Eluting Balloon Sales by End User (2013-2018) (K Units)
Table Middle East and Africa Drug-Eluting Balloon Sales Market Share by End User (2013-2018)
Figure 2017 Middle East and Africa Drug-Eluting Balloon Market Share by End User
Table Boston Scientific Company Details
Table Boston Scientific Drug-Eluting Balloon Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Boston Scientific Recent Development
Table Medtronic Company Details
Table Medtronic Drug-Eluting Balloon Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Medtronic Recent Development
Table Cook Medical Company Details
Table Cook Medical Drug-Eluting Balloon Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Cook Medical Recent Development
Table C.R. Bard Company Details
Table C.R. Bard Drug-Eluting Balloon Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table C.R. Bard Recent Development
Table B. Braun Company Details
Table B. Braun Drug-Eluting Balloon Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table B. Braun Recent Development
Table Eurocor GmbH Company Details
Table Eurocor GmbH Drug-Eluting Balloon Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Eurocor GmbH Recent Development
Table Blue Medical Company Details
Table Blue Medical Drug-Eluting Balloon Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Blue Medical Recent Development
Table Bayer Company Details
Table Bayer Drug-Eluting Balloon Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Bayer Recent Development
Table Aachen Resonance Company Details
Table Aachen Resonance Drug-Eluting Balloon Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Aachen Resonance Recent Development
Table Acrostak Company Details
Table Acrostak Drug-Eluting Balloon Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Acrostak Recent Development
Table Global Drug-Eluting Balloon Sales Forecast by Regions 2018-2025 (K Units)
Table Global Drug-Eluting Balloon Sales Market Share Forecast by Regions 2018-2025
Table Global Drug-Eluting Balloon Revenue Forecast by Regions 2018-2025 (Million US$)
Table Global Drug-Eluting Balloon Revenue Market Share Forecast by Regions 2018-2025
Table Global Drug-Eluting Balloon Sales Forecast by Product 2018-2025 (K Units)
Table Global Drug-Eluting Balloon Sales Market Share Forecast by Product 2018-2025
Table Global Drug-Eluting Balloon Revenue Forecast by Product 2018-2025 (Million US$)
Table Global Drug-Eluting Balloon Revenue Market Share Forecast by Product 2018-2025
Table Global Drug-Eluting Balloon Sales Forecast by End User 2018-2025 (K Units)
Table Global Drug-Eluting Balloon Sales Market Share Forecast by End User 2018-2025
Figure North America Drug-Eluting Balloon Sales Growth Rate Forecast (2018-2025) (K Units)
Figure North America Drug-Eluting Balloon Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Europe Drug-Eluting Balloon Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Europe Drug-Eluting Balloon Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Asia Pacific Drug-Eluting Balloon Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Asia Pacific Drug-Eluting Balloon Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Central & South America Drug-Eluting Balloon Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Central & South America Drug-Eluting Balloon Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Middle East and Africa Drug-Eluting Balloon Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Middle East and Africa Drug-Eluting Balloon Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Forecast of Global Middle-Class Population, 2015 to 2030
Figure Household Disposable Income Gross adjusted, US dollars/capita, 2016
Table Drug-Eluting Balloon Value Chain
Table Drug-Eluting Balloon Customers List
Table Drug-Eluting Balloon Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...